Can multidrug-resistant candida auris be reliably identified in clinical microbiology laboratories?

Journal of Clinical Microbiology

Volumn 55, Issue 2, 2017, Pages 638-640

  Mizusawa, Masako ^a   Miller, Heather ^a,b   Green, Rachel ^b   Lee, Richard ^b   Durante, Mariann ^c   Perkins, Rosalie ^d   Hewitt, Caroline ^d   Simner, Patricia J ^a,b   Carroll, Karen C ^a,b   Hayden, Randall T ^d   Zhang, Sean X ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

API; BD Phoenix; Bruker MS; Candida auris; Candida duobushaemulonii; Candida haemulonii; MALDI TOF MS; MicroScan; Vitek; Vitek MS

Indexed keywords

INTERNAL TRANSCRIBED SPACER;

CANDIDA; CANDIDA AURIS; CANDIDA DUOBUSHAEMULONII; CANDIDA FAMATA; CANDIDA HAEMULONII; CANDIDA PARAPSILOSIS; CLAVISPORA LUSITANIAE; CLINICAL LABORATORY; FUNGAL ISOLATE; FUNGAL PHENOMENA AND FUNCTIONS; FUNGUS IDENTIFICATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEYEROZYMA GUILLIERMONDII; MICROBIOLOGY TEST; MULTIDRUG RESISTANCE; NONHUMAN; PHYLOGENY; PICHIA KUDRIAVZEVII; SACCHAROMYCES; SHORT SURVEY; CANDIDIASIS; CLASSIFICATION; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROCEDURES;

CANDIDA; CANDIDIASIS; DRUG RESISTANCE, MULTIPLE, FUNGAL; HUMANS; MICROBIOLOGICAL TECHNIQUES; MYCOLOGICAL TYPING TECHNIQUES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 85012014882     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02202-16     Document Type: Short Survey

References (6)

1. Pan American Health Organization/World Health Organization. 3 October 2016. Epidemiological alert: Candida auris outbreaks in health care services. Regional Office for the Americas of the World Health Organization, Washington, DC. http://www.paho.org/hq/index.php?option-com- docman&task-doc-view&Itemid-270&gid-36354&lang-en.
2. Centers for Disease Control and Prevention. 2016. Clinical alert to U.S. healthcare facilities-June 2016: Global emergence of invasive infections caused by the multidrug-resistant yeast Candida auris. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/fungal/diseases/candidiasis/candida-auris-alert.html.
3. Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, Jain S, Kathuria S, Randhawa HS, Hagen F, Meis JF. 2013. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis 19:1670-1673. https://doi.org/10.3201/eid1910.130393.
4. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, Meis JF, Chowdhary A. 2015. Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol 53:1823-1830. https://doi.org/10.1128/JCM.00367-15.
5. Fraser M, Brown Z, Houldsworth M, Borman AM, Johnson EM. 2016. Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database. Med Mycol 54:80-88. https://doi.org/10.1093/mmy/myv085.
6. Borman AM, Szekely A, Johnson EM. 2016. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species. mSphere 1(4):e00189-16. https://doi.org/10.1128/mSphere.00189-16.